78. 5 Experts & 1 Episode. Unfiltered Moments You Won’t Forget

From entrepreneurial leaps to the future of bypass, the most powerful moments from the past months are here.In this best-of episode, we revisit conversations with some of the sharpest minds in MedTech, vascular surgery, cardiology, and education, including ICHOR Founder and CEO Tim Blair, interventional cardiologist Dr. Jaafer Golzar, interventional angiologist Dr. Michael Lichtenberg, bilingual parenting expert Michelle Bruni and Scott Addonizio, COO of BrosMed Medical and President of BrosMed US.Each guest shares something unforgettable: what it really takes to build a company from scratch, when to push for new treatment paths, how to think differently about bypass, and why raising a bilingual child is more science-backed than most experts still realize.We also hear from Life of Flow Podcast hosts Miguel and Lucas themselves reflecting on the pressure of high-stakes surgery, the value of micro-breaks, and what they’d change about how surgeons are trained today.♦️ 00:46 The #1 Mistake Founders Make With Their Startups | LOF #7102:15 What pushed Tim Blair to walk away from a secure MedTech career04:48 Taking the leap: navigating risk, payroll, and belief♦️ 11:45 The Procedure That’s Forcing Surgeons to Rethink Bypass | LOF #7213:50 PTAB: the new bypass option that changed Dr. Golzar’s practice17:01 When surgeons might consider PTAB over open bypass♦️ 20:57 This World-Renowned Doctor Is Exposing the Biggest Flaw in Modern Vascular Care | LOF #7323:00 What vascular care needs less (and more) of25:49 Young patients, disabling disease, and no viable answers♦️ 29:07 Should You Raise Your Kid Bilingual? Bilingual Expert Reveals What Parents Miss | LOF #7429:37 Michelle Bruni explains the best age to start bilingual parenting31:48 Common myths around speech delays in bilingual kids♦️ 35:29 Why Surgeons Are Obsessed With This AI Tool | LOF #7535:42 The worst advice Miguel ever received in training38:25 Miguel’s spiritual ritual before the OR♦️45:51 Trump’s Tariffs Are Crippling MedTech - Here’s What Comes Next | LOF #7746:04 What it felt like when MedTech tariffs suddenly hit 145%53:18 His vision for future-proofing BrosMed with U.S. manufacturing💡 Who Should ListenVascular surgeons, MedTech founders, interventional cardiologists, and early-career physicians looking for raw, honest reflections on career pivots, clinical decision-making, and the future of patient care.About our GuestsTimothy Blair is the CEO and Co-Founder of ICHOR Vascular Inc. He brings 33+ years of experience across leadership roles in sales, marketing, clinical strategy, and venture due diligence, with a background at Smiths Medical, AngioDynamics, and NAMSA.Dr. Jaafer Golzar is an interventional cardiologist, Director of Limb Salvage & Endovascular Intervention at Advocate Trinity Hospital, and Clinical Assistant Professor of Medicine at the University of Illinois at Chicago. His expertise includes endovascular interventions and clinical trial leadership across multiple specialties.Dr. Michael Lichtenberg is a German interventional angiologist with two decades of experience and a former President of the German Society for Angiology. He is known for his work evaluating new tools for peripheral artery disease and his role in founding PEO, CLI-congress, and the European MedTech Startup SharkTank.Michelle Bruni is a bilingual parenting educator and PhD psychologist helping families raise confident bilingual children. She blends science and storytelling through her online education platform and personal parenting experience.Scott Addonizio is COO of BrosMed Medical and President of BrosMed US. His experience spans global supply chains, IDE approvals, and U.S. manufacturing strategy for vascular devices.Follow Life of Flow📲 Instagram: @LifeofFlowPodcast👍 Facebook: Life of Flow Podcast💼 LinkedIn: Life of Flow Podcast🐦 X: @VascularPodcastWe appreciate you being here! more to come.